组织病理学证实的脑放射性损伤——放射参数与时空分布的深度分析
该研究纳入33例光子放疗后经组织病理学证实的放射性损伤患者,分析其剂量学参数与时空分布。高级别胶质瘤患者多在单程常规分割放疗(中位累积EQD2 60 Gy)后出现损伤,而脑转移患者多在≥2程立体定向放疗后出现(中位累积EQD2 162.4 Gy)。所有损伤灶均位于既往放疗靶区内,SVZ受累病灶的累积EQD2显著更低。
要点
- 高级别胶质瘤患者接受加速超分割放疗可在计算EQD2和BED2较低时出现放射性损伤。
- 所有34个放射性损伤病灶均位于至少一程既往放疗的PTV内。
- SVZ受累的放射性损伤病灶累积EQD2显著低于未受累病灶(中位60 Gy vs 141 Gy,p=0.01)。
核心结论
- 高级别胶质瘤患者接受加速超分割放疗时,尽管计算EQD2和BED2较低,仍可导致放射性损伤。
- 放射性损伤的解剖位置与胶质瘤和转移瘤的总体肿瘤分布相对应。
- SVZ可能是特别易损的区域。
研究设计与样本
- 纳入光子放疗后经组织病理学证实发生放射性损伤的原发性或继发性中枢神经系统恶性肿瘤病例。
- 从患者记录和治疗计划系统收集人口学、临床和剂量学数据。
- 计算正常脑组织(α/β比值为2 Gy)的2 Gy分次等效剂量(EQD2)和生物有效剂量(BED2),并使用频率图分析时空分布。
- 共识别33例患者。
主要发现
- 高级别胶质瘤患者(n=18)多在诊断放射性损伤前接受一程常规分割放疗,中位累积EQD2为60 Gy,中位PTV为203.9 ccm。
- 3例接受加速超分割放疗的患者尽管EQD2和BED2较低,仍发生放射性损伤。
- 脑转移患者(n=15;16个放射性损伤病灶)多接受两程或以上放疗,采用放射外科或分次立体定向放疗,中位累积EQD2为162.4 Gy,中位PTV为6.7 ccm。
- 全部34个放射性损伤病灶均位于至少一程既往放疗的PTV内。
- 高级别胶质瘤组的放射性损伤呈额颞分布模式,而转移瘤患者的放射性损伤遍布全脑,以顶叶密度最高。
关键数值与推荐
- 高级别胶质瘤患者中位累积EQD2为60 Gy,中位PTV为203.9 ccm。
- 脑转移患者中位累积EQD2为162.4 Gy,中位PTV为6.7 ccm。
- SVZ受累病灶与未受累病灶的中位累积EQD2分别为60 Gy与141 Gy(p=0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radiation-induced damage (RID) after radiotherapy (RT) of primary brain tumors and metastases can be challenging to clinico-radiographically distinguish from tumor progression. RID includes pseudoprogression and radiation necrosis; the latter being irreversible and often associated with severe symptoms. While histopathology constitutes the diagnostic gold standard, biopsy-controlled clinical studies investigating RID remain limited. Whether certain brain areas are potentially more vulnerable to RID remains an area of active investigation. Here, we analyze histopathologically confirmed cases of RID in relation to the temporal and spatial dose distribution. METHODS: Histopathologically confirmed cases of RID after photon-based RT for primary or secondary central nervous system malignancies were included. Demographic, clinical, and dosimetric data were collected from patient records and treatment planning systems. We calculated the equivalent dose in 2 Gy fractions (EQD22) and the biologically effective dose (BED2) for normal brain tissue (α/β ratio of 2 Gy) and analyzed the spatial and temporal distribution using frequency maps. RESULTS: Thirty-three patients were identified. High-grade glioma patients (n = 18) mostly received one normofractionated RT series (median cumulative EQD22 60 Gy) to a large planning target volume (PTV) (median 203.9 ccm) before diagnosis of RID. Despite the low EQD22 and BED2, three patients with an accelerated hyperfractionated RT developed RID. In contrast, brain metastases patients (n = 15; 16 RID lesions) were often treated with two or more RT courses and with radiosurgery or fractionated stereotactic RT, resulting in a higher cumulative EQD22 (median 162.4 Gy), to a small PTV (median 6.7 ccm). All (n = 34) RID lesions occurred within the PTV of at least one of the preceding RT courses. RID in the high-grade glioma group showed a frontotemporal distribution pattern, whereas, in metastatic patients, RID was observed throughout the brain with highest density in the parietal lobe. The cumulative EQD22 was significantly lower in RID lesions that involved the subventricular zone (SVZ) than in lesions without SVZ involvement (median 60 Gy vs. 141 Gy, p = 0.01). CONCLUSIONS: Accelerated hyperfractionated RT can lead to RID despite computationally low EQD22 and BED2 in high-grade glioma patients. The anatomical location of RID corresponded to the general tumor distribution of gliomas and metastases. The SVZ might be a particularly vulnerable area.
引用
- Kossmann MRP, Ehret F, Roohani S, et al. Histopathologically confirmed radiation-induced damage of the brain - an in-depth analysis of radiation parameters and spatio-temporal occurrence. Radiat Oncol. 2023. PMID: 38087368. doi:10.1186/s13014-023-02385-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。